KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Honeywell International (HON) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Honeywell International (HON) over the last 17 years, with Q4 2025 value amounting to $12.5 billion.

  • Honeywell International's Cash & Equivalents rose 2605.49% to $12.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $12.5 billion, marking a year-over-year increase of 2605.49%. This contributed to the annual value of $12.5 billion for FY2025, which is 2605.49% up from last year.
  • Latest data reveals that Honeywell International reported Cash & Equivalents of $12.5 billion as of Q4 2025, which was up 2605.49% from $12.9 billion recorded in Q3 2025.
  • In the past 5 years, Honeywell International's Cash & Equivalents registered a high of $12.9 billion during Q3 2025, and its lowest value of $6.9 billion during Q1 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $9.8 billion (2024), whereas its average is $9.9 billion.
  • As far as peak fluctuations go, Honeywell International's Cash & Equivalents plummeted by 3281.32% in 2022, and later surged by 7114.57% in 2024.
  • Over the past 5 years, Honeywell International's Cash & Equivalents (Quarter) stood at $11.0 billion in 2021, then decreased by 12.15% to $9.6 billion in 2022, then dropped by 17.68% to $7.9 billion in 2023, then increased by 25.0% to $9.9 billion in 2024, then rose by 26.05% to $12.5 billion in 2025.
  • Its Cash & Equivalents was $12.5 billion in Q4 2025, compared to $12.9 billion in Q3 2025 and $10.3 billion in Q2 2025.